Technology News and Research

RSS

Neuroscientists say that general anesthesia is a reversible coma

The brain under general anesthesia isn't "asleep" as surgery patients are often told -- it is placed into a state that is a reversible coma, according to three neuroscientists who have published an extensive review of general anesthesia, sleep and coma, in the Dec. 30 issue of The New England Journal of Medicine.

30 Dec 2010

ISCO to conduct discussion on ethical and medical advantages of human parthenogenetic stem cells

International Stem Cell Corporation, will lead a free public discussion highlighting the ethical considerations and medical advantages surrounding the derivation of human stem cells from unfertilized human eggs using ISCO's patented technology known as parthenogenesis.

29 Dec 2010

Florida Hospital, Sanford-Burnham and Takeda enter obesity research collaboration

Florida Hospital, Sanford-Burnham Medical Research Institute (Sanford-Burnham), and Takeda Pharmaceutical Company Limited (Takeda)(TSE: 4502), announced today that they have signed a research agreement to form a collaboration to discover and evaluate new therapeutic approaches to obesity, a growing worldwide health problem. The partnership aligns complementary strengths in biomedical research, clinical research and drug development to identify and validate obesity- related biomarkers and new peripheral molecular targets of mutual interest.

29 Dec 2010

Crothall partners with 3M to implement effective infection control

Crothall Healthcare, a premier provider of support services to healthcare clients, announced its Preferred Partnership arrangement with 3M to kick-off its powerfully enhanced approach to infection control.

29 Dec 2010

Researchers develop breath-analysis technology for rapid detection of biomarkers

Researchers have overcome a fundamental obstacle in developing breath-analysis technology to rapidly diagnose patients by detecting chemical compounds called "biomarkers" in a person's respiration in real time.

29 Dec 2010

Natus Medical ships ALGO hearing screeners to New South Wales

Natus Medical Incorporated today announced that it was awarded, and has shipped, a $1.3 million order for its ALGO hearing screeners from New South Wales, Australia's most populous state.

29 Dec 2010

NEI awards Case Western Reserve $10M for study of retinal diseases

The Departments of Pharmacology and Ophthalmology and Visual Sciences at Case Western Reserve University School of Medicine have been awarded a $10.1 million grant from the National Eye Institute (NEI) to research and develop new treatments for diseases of the retina, a leading cause of blindness.

29 Dec 2010

Proellex vaginal delivery exhibits four times activity of oral dose in animal study

Repros Therapeutics Inc. today announced it has completed two animal model studies of the use of Proellex® in a vaginally administered formulation that demonstrated effects on progesterone sensitive tissues equivalent to the highest oral dose formerly in development by the Company.

28 Dec 2010

Myrexis initiates controlled two-arm Azixa Phase 2b clinical study in glioblastoma multiforme

EpiCept Corporation today reported that Myrexis, Inc. has initiated a controlled two-arm Phase 2b clinical study of Azixa™ as a front-line treatment for glioblastoma multiforme (GBM). Azixa™, a vascular disruption agent with potent anti-cancer activity, was discovered by EpiCept as part of its ASAP technology platform and licensed to Myrexis.

28 Dec 2010

ACT, Roslin Cells collaborate to establish hESC line bank using single-ceblastomere technique

Advanced Cell Technology, a leader in the field of regenerative medicine, announced today that it has entered into a Memorandum of Understanding with Roslin Cells LTD of Scotland, in which the two companies contemplate a definitive collaboration agreement in the near future.

28 Dec 2010

King Pharmaceuticals resubmits NDA for REMOXY

King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. today announced that King has resubmitted a New Drug Application for REMOXY® to the U.S. Food and Drug Administration in response to a Complete Response letter received by Pain Therapeutics in December 2008.

28 Dec 2010

NDA resubmitted for DURECT's ORADUR technology based REMOXY

DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.

28 Dec 2010

Exiqon announces introduction of GLP compliant services for miRNA biomarker screening

Exiqon A/S, a leading provider of technologies for biomarker detection, today announced the introduction of GLP compliant services for miRNA biomarker screening and diagnostic assay development for clinical trials.

27 Dec 2010

Pros and cons of apps for common New Year's resolutions

With about 400,000 apps available for Smartphones and news ones added daily, there is an app for almost everything, from losing weight to finding a job.

24 Dec 2010

Male partners' sympathy levels during menstrual periods lacking

New research from Lloydspharmacy reveals that whilst an overwhelming number of women suffer from menstrual cramps, male partners' sympathy levels at that time of the month appear to be lacking. Although 87% of men claim to be very or fairly compassionate, a quarter of women (25%) who have suffered discomfort with 'Mother Nature's gift' say their partners are unsympathetic.

24 Dec 2010

High pressure technology holds promise for decontamination of dairy products

The AZTI-Tecnalia technological centre, in a project undertaken by the Tecnolat and Llet de Catalunya dairy product companies within the FUTURAL project, has verified that, as an alternative to the traditional heat treatment for decontamination of a number of dairy products, high pressure technology is highly recommendable. In fact, according to a press release from Tecnolat, the results, especially with ready-to-eat fruit products and in the inactivation of moulds and yeasts in other dairy products, "were highly positive and promising".

24 Dec 2010

$1.1 billion Martek sale measures success of UMD-Mtech 'grads'

The latest success of Martek Biosciences, a rising-star among Maryland biotechs, began more than a decade ago in a plain, brick building on the University of Maryland campus. With a good idea and early-stage nurturing from the university's Maryland Technology Enterprise Institute (Mtech), the company has been able to grow into a major international business.

24 Dec 2010

Meaningful use of EHR systems is an IT and organizational initiative

Meaningful use of Electronic Health Record (EHR) systems is more than an IT or clinical initiative, according to Reonel "Joon" Saddul, Vice President, Clinical Informatics, at St. Joseph Health System. It is an organizational initiative. Implementation could cost the organization three times more than it should, if not done right from the start, therefore, Saddul advises that all parties are included in the decision-making and planning processes, and the projects aligned to known and likely future requirements.

24 Dec 2010

HIT interventions promising tools in fight to improve medication adherence, despite paucity of data

A new study that reviews more than four decades of medical journal articles about the impact of health information technology (HIT) and electronic communications on medication adherence concludes that while there is evidence to suggest that simple electronic reminders are an effective and low-cost means to improve adherence, there are few studies that show how HIT can be leveraged to more thoughtfully engage or motivate patients to take medications as prescribed.

24 Dec 2010

Good Clostridia prevents development of allergies and inflammatory bowel disease

Scientists at the University of Tokyo have discovered that specific gut-dwelling bacteria control key immune cells that combat allergies and autoimmune diseases. The paper describing these findings was published in today's issue of the journal Science, and technology originating from the work is being advanced by start-up Vedanta Biosciences.

24 Dec 2010

Technology News and Research

Neuroscientists say that general anesthesia is a reversible coma

ISCO to conduct discussion on ethical and medical advantages of human parthenogenetic stem cells

Florida Hospital, Sanford-Burnham and Takeda enter obesity research collaboration

Crothall partners with 3M to implement effective infection control

Researchers develop breath-analysis technology for rapid detection of biomarkers

Natus Medical ships ALGO hearing screeners to New South Wales

NEI awards Case Western Reserve $10M for study of retinal diseases

Proellex vaginal delivery exhibits four times activity of oral dose in animal study

Myrexis initiates controlled two-arm Azixa Phase 2b clinical study in glioblastoma multiforme

ACT, Roslin Cells collaborate to establish hESC line bank using single-ceblastomere technique

King Pharmaceuticals resubmits NDA for REMOXY

NDA resubmitted for DURECT's ORADUR technology based REMOXY

Exiqon announces introduction of GLP compliant services for miRNA biomarker screening

Pros and cons of apps for common New Year's resolutions

Male partners' sympathy levels during menstrual periods lacking

High pressure technology holds promise for decontamination of dairy products

$1.1 billion Martek sale measures success of UMD-Mtech 'grads'

Meaningful use of EHR systems is an IT and organizational initiative

HIT interventions promising tools in fight to improve medication adherence, despite paucity of data

Good Clostridia prevents development of allergies and inflammatory bowel disease

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News